FDA news
Read verified news on BetaVoices covering FDA, with reporting, context, and related developments.
Food safety
Nara organic infant formula recalled after 3 botulism cases
The voluntary recall covers whole milk powdered infant formula sold in the U.S. through Target, Target.com and Nara.com, according to an FDA notice
Experimental obesity drugs
Safety questions grow around experimental weight-loss drugs
CBS News reported concerns over doctors prescribing retatrutide before FDA approval, while separate trial data for Zealand Pharma’s survodutide rattled investors over side effects
Vaccine safety research
HHS confirms FDA withdrew studies on Covid and shingles vaccine safety
An HHS spokesperson said the studies drew conclusions not supported by the data; reporting cited FDA work with firms to analyze millions of patient records
FDA scrutiny
FDA’s Makary defends drug rejections amid backlash
The FDA commissioner told CNBC he stands with agency scientists after criticism over recent decisions, including the rejection of Replimune’s melanoma drug candidate
Drug compounding
FDA proposal would curb bulk compounding of Novo, Lilly weight-loss drugs
The agency says it sees no clinical need for outsourcing facilities to make bulk compounded versions of semaglutide, tirzepatide and liraglutide when approved drugs are available